v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Apr. 30, 2024
Cash flows from operating activities:      
Net income $ 280,820 $ 251,076 $ 172,561
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 98,844 80,287 77,966
Stock-based compensation expense 47,682 47,961 39,970
Provision for doubtful accounts 16,262 20,676 20,715
Gain on marketable securities (31,939) (17,105) (29,848)
Gain on modification of office lease (13,907) 0 0
Gain on cash surrender value of life insurance policies (11,557) (11,597) (8,803)
Deferred income taxes 31,821 (6,404) (32,309)
Impairment of right-of-use assets 0 2,452 1,629
Impairment of fixed assets 0 509 1,575
Change in other assets and liabilities:      
Deferred compensation 42,765 41,462 65,402
Accounts payable and accrued liabilities 36,046 (1,976) (54,712)
Receivables due from clients (24,357) (33,243) 7,872
Income taxes and other receivables (21,513) 5,711 13,669
Prepaid expenses and other assets (16,949) 7,997 (239)
Unearned compensation (14,399) (9,454) 7,923
Income taxes payable (4,576) (5,349) 2,617
Other (851) (8,641) (2,027)
Net cash provided by operating activities 414,192 364,362 283,961
Cash flows from investing activities:      
Purchase of property and equipment (89,899) (62,484) (55,147)
Proceeds from sales/maturities of marketable securities 53,007 41,921 46,000
Purchase of marketable securities (36,922) (39,453) (45,768)
Premium on company-owned life insurance policies (28,383) (28,440) (15,185)
Proceeds from life insurance policies 3,479 7,359 16,272
Cash paid for acquisitions, net of cash acquired 0 (44,442) 0
Dividends received from unconsolidated subsidiaries 0 40 0
Net cash used in investing activities (98,718) (125,499) (53,828)
Cash flows from financing activities:      
Dividends paid to shareholders (104,645) (83,632) (54,391)
Repurchases of common stock (115,710) (88,819) (53,162)
Payments of tax withholdings on restricted stock (19,206) (17,351) (10,732)
Proceeds from issuance of common stock in connection with an employee stock purchase plan 7,516 7,868 8,347
Dividends paid to noncontrolling interest (3,656) (3,038) (4,496)
Principal payments on finance leases (2,071) (1,631) (1,776)
Payments on life insurance policy loans (653) (4,127) (123)
Net cash used in financing activities (238,425) (190,730) (116,333)
Effect of exchange rate changes on cash and cash equivalents 11,432 17,826 (16,819)
Net increase in cash and cash equivalents 88,481 65,959 96,981
Cash and cash equivalents at beginning of year 1,006,964 941,005 844,024
Cash and cash equivalents at end of the year 1,095,445 1,006,964 941,005
Supplemental cash flow information:      
Cash used to pay interest 24,773 25,249 24,992
Cash used to pay income taxes, net of refunds $ 89,770 $ 106,900 $ 72,124

Source

PDF